FindTrial
Sign In

Multicenter prospective cohort study of remission induction and maintainance effects of anti-TNFagents for Crohn's jejunoileitis.

Multicenter prospective cohort study of remission induction and maintainance effects of anti-TNFagents for Crohn's jejunoileitis. - Effects of Anti-TNFagents for Crohn's jejunoileitis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000008486
Enrollment
400
Registered
2012-07-20
Start date
2012-09-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suspected and documented Cron&#39

Interventions

Infliximab Adalimumab Immunomodulator Diet therapy

Sponsors

Nagoya University Graduate School of Medicine, Department of Gastroenterology and Hepatology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with susupected or documented Crohn's jejunoileitis

Exclusion criteria

Exclusion criteria: Contraindications of anti-TNF agents

Design outcomes

Primary

MeasureTime frame
Changes of enteroscopic findings—

Secondary

MeasureTime frame
CDAI, IOIBD, CRP, Adverse events of anti-TNF agents and patency capsule endoscopy, etc.—

Countries

Japan

Contacts

Public ContactNaoki Ohmiya

Fujita Health University School of Medicine Department of Gastroenterology and Hepatology

nohmiya@med.nagoya-u.ac.jp0562-93-9240

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026